Abstract
Acute myocardial infarction (AMI) impairs the myocardium ability to pump blood. If this condition is not reversed in time, it will compromise the entire cardiovascular system, which in turn can lead to the collapse of all other physiological systems. Therefore, for the rapid and correct management of this condition the role played by the clinical pathology laboratory (CPL) is crucial due to its rapid response in the quantification of cardiac biomarkers. Through the measurements realized in CPL, it is possible to not only diagnose myocardial injury but also evaluate the injury size, establish a prognostic, or estimate the risk of re-infarction. Currently, the data provided by CPL to the clinician is increasingly accurate and robust, which is only possible due to the evolution that has been made in this field during the last three decades. Therefore, the major objective of this review is to emphasize the relevance that CPL has in the management of AMI patients.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
